BASEL, Switzerland and LONDON and NEW YORK, May 11, 2026 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Wednesday, ...
Patient accrual complete for 1L HCC Phase 2 randomized clinical trial for anti-IL27 casdozokitug,timing for data readouts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results